References
1. Mitchell JR, Thorgeirsson SS, Potter WZ, Jollow DJ, Keiser H.
Acetaminophen‐induced hepatic injury: Protective role of glutathione in
man and rationale for therapy. Clin Pharm Ther . 1974;4:676-684.
2. Prescott LF, Park J, Ballantyne A, et al. Treatment of paracetamol
(acetaminophen) poisoning with N-acetylcysteine. . Lancet .
1977;2(8035):432-434.
3. Prescott LF, Sutherland GR, Park J, Smith IJ, Proudfoot AT.
Cysteamine, methionine, and penicillamine in the treatment of
paracetamol poisoning. Lancet . 1976;2(7977):109-113.
4. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD,
Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for
paracetamol poisoning. Br Med J . 1979;2(6198):1097-1100.
5. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral
N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of
the national multicenter study (1976 to 1985). N Engl J Med .
1988;319(24):1557-1562. doi:10.1056/NEJM198812153192401
6. Rumack BH, Bateman DN. Acetaminophen and acetylcysteine dose and
duration: Past, present and future. Clin Toxicol .
2012;50(2):91-98. doi:10.3109/15563650.2012.659252
7. Bateman DN, Dear JW. Acetylcysteine in paracetamol poisoning: A
perspective of 45 years of use. Toxicol Res (Camb) .
2019;8(4):489-498. doi:10.1039/c9tx00002j
8. Bateman DN, Dear JW, Thanacoody HKR, et al. Reduction of adverse
effects from intravenous acetylcysteine treatment for paracetamol
poisoning: A randomised controlled trial. Lancet .
2014;383(9918):697-704. doi:10.1016/S0140-6736(13)62062-0
9. Chiew A, Gluud C, Brok J, Buckley N. Interventions for paracetamol (
acetaminophen ) overdose. Cochrane Database Syst Rev .
2018;(2):1-90.
doi:10.1002/14651858.CD003328.pub3.www.cochranelibrary.com
10. Ferner RE, Dear JW, Bateman DN. Management of paracetamol poisoning.Bmj . 2011;342(7804):968-972. doi:10.1136/bmj.d2218
11. Mitchell JR, Thorgeirsson SS, Potter WZ, Jollow DJ, Keiser H.
Acetaminophen-induced hepatic injury: protective role of glutathione in
man and rationale for therapy. Clin Pharmacol Ther .
1974;16(4):676-684.
12. Forrest JA, Clements JA, Prescott LF. Clinical pharmacokinetics of
paracetamol. Clin Pharmacokinet . 1982;7(2):93-107.
13. Cairney DG, Beckwith HKS, Al-Hourani K, Eddleston M, Bateman DN,
Dear JW. Plasma paracetamol concentration at hospital presentation has a
dose-dependent relationship with liver injury despite prompt treatment
with intravenous acetylcysteine. Clin Toxicol . 2016;54:405-410.
14. Marks DJ, Dargan PI, Archer JR, et al. Outcomes from massive
paracetamol overdose: a retrospective observational study. Br J
Clin Pharmacol . 2017;(83):1263-1272.
15. Chiew AL, Isbister GK, Duffull SB, Buckley NA. Evidence for the
changing regimens of acetylcysteine. Br J Clin Pharmacol .
2016;81(3):471-481. doi:10.1111/bcp.12789
16. Bateman DN, Dear JW. Should we treat very large paracetamol overdose
differently? Br J Clin Pharmacol . 2017;83(6):1163-1165.
doi:10.1111/bcp.13279
17. Hendrickson RG. What is the most appropriate dose of N
-acetylcysteine after massive acetaminophen overdose? Clin
Toxicol . 2019;57(0):686-691. doi:10.1080/15563650.2019.1579914
18. Yan M, Huo Y, Yin S, Hu H. Mechanisms of acetaminophen-induced liver
injury and its implications for therapeutic interventions. Redox
Biol . 2018;17(April):274-283. doi:10.1016/j.redox.2018.04.019
19. Ramachandran A, Jaeschke H. Mechanisms of acetaminophen
hepatotoxicity and their translation to the human pathophysiology.J Clin Transl Res . 2017;3:157-169.
doi:10.18053/jctres.03.2017s1.002
20. Jaeschke H, Ramachandran A. Acetaminophen Toxicity: Novel Insights
Into Mechanisms and Future Perspectives. Gene Expr .
2018;18:19-30. doi:10.3727/105221617X15084371374138
21. Ezeriņa D, Takano Y, Hanaoka K, Urano Y, Dick TP. N-Acetyl Cysteine
Functions as a Fast-Acting Antioxidant by Triggering Intracellular H 2 S
and Sulfane Sulfur Production. Cell Chem Biol .
2018;25(4):447-459.e4. doi:10.1016/j.chembiol.2018.01.011
22. Rushworth GF, Megson IL. Existing and potential therapeutic uses for
N-acetylcysteine: The need for conversion to intracellular glutathione
for antioxidant benefits. Pharmacol Ther . 2014;141(2):150-159.
doi:10.1016/j.pharmthera.2013.09.006
23. Karuppagounder SS, Alin L, Chen Y, et al. N-acetylcysteine targets 5
lipoxygenase-derived, toxic lipids and can synergize with prostaglandin
E2 to inhibit ferroptosis and improve outcomes following hemorrhagic
stroke in mice. Ann Neurol . 2018;84(6):854-872.
doi:10.1002/ana.25356
24. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine
in paracetamol induced fulminant hepatic failure: a prospective
controlled trial. Bmj . 1991;303(6809):1026-1029.
25. Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R. Improved
outcome of paracetamol-induced fulminant hepatic failure by late
administration of acetylcysteine. Lancet .
1990;335(8705):1572-1573.
26. Ghannoum M, Kazim S, Grunbaum AM, Villeneuve E, Gosselin S. Massive
acetaminophen overdose: effect of hemodialysis on acetaminophen and
acetylcysteine kinetics. Clin Toxicol (Phila) .
2016;54(6):519-522. doi:10.1080/15563650.2016.1175006
27. Gosselin S, Juurlink DN, Kielstein JT, et al. Extracorporeal
treatment for acetaminophen poisoning: recommendations from the EXTRIP
workgroup. Clin Toxicol . 2014;52(8):856-867.
doi:10.3109/15563650.2014.946994
28. Woolum JA, Hays WB, Patel KH. Use of fomepizole, n-acetylcysteine,
and hemodialysis for massive acetaminophen overdose. Am J Emerg
Med . 2020;38(3):692.e5-692.e7. doi:10.1016/j.ajem.2019.09.026
29. Morrison EE, Oatey K, Gallagher B, et al. Principal results of a
randomised open label exploratory, safety and tolerability study with
calmangafodipir in patients treated with a 12 h regimen of
N-acetylcysteine for paracetamol overdose (POP trial).EBioMedicine . 2019;46:423-430. doi:10.1016/j.ebiom.2019.07.013
30. Mullins ME, Yeager LH, Freeman WE. Metabolic and mitochondrial
treatments for severe paracetamol poisoning: a systematic review.Clin Toxicol . 2020;58(12):1284-1296.
doi:10.1080/15563650.2020.1798979
31. Caparrotta TM, Antoine DJ, Dear JW. Are some people at increased
risk of paracetamol-induced liver injury? A critical review of the
literature. Eur J Clin Pharmacol . 2018;74(2):147-160.
doi:10.1007/s00228-017-2356-6
32. Vliegenthart AD, Kimmitt RA, Seymour JH, et al. Circulating
acetaminophen metabolites are toxicokinetic biomarkers of acute liver
injury. Clin Pharmacol Ther . 2016;10. doi:10.1002/cpt.541
33. Dear JW. New Biomarkers for Drug-Induced Liver Injury.Hepatology . 2018;67(6):2479-2480. doi:10.1002/hep.29825
34. Nuzzo A, Salem S, Malissin I, et al. in acetaminophen poisoning : A
prospective cohort study. U E G J . 2021;9:571-580.
doi:10.1002/ueg2.12093
35. Pettie JM, Caparrotta TM, Hunter RW, et al. Safety and Efficacy of
the SNAP 12-hour Acetylcysteine Regimen for the Treatment of Paracetamol
Overdose. EClinicalMedicine . 2019;11:11-17.
doi:10.1016/j.eclinm.2019.04.005